BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 572515)

  • 1. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of the DNCB skin test and CEA assay in the prognosis of malignant neoplasms].
    Ciambellotti E; Moro G
    Arch Sci Med (Torino); 1983; 140(3):267-72. PubMed ID: 6675584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D; Körner E; Haneke E
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
    Bianucci P; Pastorino G; Brondi P
    Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin reactivity to dinitrochlorobenzene in cancer patients.
    Jassem J; Serkies K
    Neoplasma; 1980; 27(5):589-93. PubMed ID: 7231615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the DNCB skin test in patients with solid neoplasms].
    Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
    Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative DNCB reaction in patients with hypernephroma].
    Kreutz G; Bandhauer K
    Z Urol Nephrol; 1980 Feb; 73(2):73-8. PubMed ID: 7445781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
    Flamm J; Burkert S
    Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "DNCB reactivity in cancer patients and during follow-up period".
    Hardas UD; Jalgaonkar SV
    Indian J Cancer; 1982; 19(5):260-2. PubMed ID: 7166344
    [No Abstract]   [Full Text] [Related]  

  • 16. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
    Rapaport FT; Lawrence HS
    Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
    J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNCB and PPD skin testing in breast cancer.
    Munzarová M; Kovarík J; Ninger E; Zemanová D; Lauerová L; Kolcová V; Hlávková J; Pacovský Z
    Neoplasma; 1983; 30(4):385-9. PubMed ID: 6888607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.